###begin article-title 0
###xml 159 165 <span type="species:ncbi:9913">bovine</span>
The effects of estrogen, its antagonist ICI 182, 780, and interferon-tau on the expression of estrogen receptors and integrin alphaV beta 3 on cycle day 16 in bovine endometrium
###end article-title 0
###begin p 1
###xml 86 87 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 91 93 84 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 415 416 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 420 422 406 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 574 575 548 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 579 581 550 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 853 854 811 812 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 858 860 813 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1608 1609 1535 1536 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1613 1615 1537 1539 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1770 1771 1690 1691 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1775 1777 1692 1694 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1971 1972 1876 1877 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1976 1978 1878 1880 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 96 102 <span type="species:ncbi:9913">bovine</span>
We have shown previously that downregulation of intercaruncular stromal integrin alphavbeta3 in bovine endometrium on day 16 of the estrous cycle coincided with the antibody recognition of estrogen receptors (ER) in the luminal epithelium. In pregnancy, these changes were not observed. Our hypothesis was that on day 16 of the estrous cycle, estrogen from the dominant follicle causes a reduction in integrin alphavbeta3 and affects ERalpha in the luminal epithelium. The pregnancy recognition protein, interferon-tau (IFN-tau), may prevent downregulation of integrin alphavbeta3 and suppress ERalpha expression in the luminal epithelium. On days 14 to 16, heifers received uterine infusions of the anti-estrogen ICI 182, 780, estradiol 17beta, IFN-tau or the saline control. On day 16, reproductive tracts were collected for analysis of integrin alphavbeta3 and ERalpha. Estrogen receptor alpha immunoreactivity was largely restricted to the luminal epithelium in control animals. Using anti-ERalpha recognizing the amino terminus, estrogen-treated animals showed reactivity in the stroma, shallow and deep glands and myometrium as is typical of estrus, whereas ICI 182, 870 treated heifers showed little or no reactivity. In contrast, carboxyl terminus-directed antibodies showed a widespread distribution of ERalpha with reactivity detected in the uterine epithelium, stroma and myometrium of both estrogen and ICI 182, 780 treated animals. Heifers treated with IFN-tau had low ERalpha reactivity overall. Control and IFN-tau treated heifers had lower intercaruncular stromal expression of integrin alphavbeta3 in comparison to estrogen and ICI 182, 780 treatments. Overall, the results suggest that on day 16 of the estrous cycle, estrogen effects on integrin alphavbeta3 are indirect and do not directly involve ERalpha in the luminal epithelium. During pregnancy, interferon-tau may block ERalpha in the luminal epithelium but likely does not rescue integrin alphavbeta3 expression.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 321 322 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 326 328 319 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 360 361 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 362 363 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 667 668 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 719 720 708 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 724 726 710 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 810 811 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 812 814 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 14 20 <span type="species:ncbi:9913">bovine</span>
###xml 697 703 <span type="species:ncbi:9913">cattle</span>
Day 16 of the bovine estrous cycle is critical as it is the last day for embryo transfer and marks the generation of the luteolytic signal in the absence of a viable conceptus [1,2]. We have identified two potential molecular markers of the day 16 uterine environment: the adhesion and signalling molecule, integrin alphavbeta3 and the estrogen receptor (ER) [3,4]. Integrins are transmembrane heterodimers that facilitate cell-cell and cell-extracellular matrix attachment. In doing so, integrins influence differentiation states of the cells on which they are expressed and adjacent cells through bi-directional signalling to and from the cell and its environment [5]. In many species including cattle, integrin alphavbeta3 is present at the fetomaternal interface during embryo attachment and implantation [6-10].
###end p 3
###begin p 4
###xml 41 42 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 43 44 43 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 88 89 84 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 93 95 86 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 155 156 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 473 474 462 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 478 480 464 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 562 563 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 564 566 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 688 689 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 755 756 737 738 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 760 762 739 741 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 853 855 829 831 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 921 923 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 924 926 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 147 153 <span type="species:ncbi:9913">cattle</span>
In comparison to other domestic animals [7,9], preferential expression of integrin alphavbeta3 in intercaruncular stromal endometrium is unique to cattle [3]. There is little expression in luminal epithelium and the stroma of the caruncles, the endometrial sites where the maternal component of the placenta will develop. Its expression is strongest in the periluminal stroma in cells in contact with the basal lamina of luminal epithelium. Downregulation of integrin alphavbeta3 in subepithelial stroma occurs on day 16 of the estrous cycle, but not pregnancy [3,10]. This downregulation coincides with a transient change in the ER in the luminal epithelium and the onset of luteolysis [4]. In support of a role for estrogens in regulating integrin alphavbeta3 expression in cyclic endometrium, downregulation of the rate limiting integrin subunit beta3 expression by estrogen is reported in cultured endometrial cells [11-13].
###end p 4
###begin p 5
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 660 662 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 663 665 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 928 929 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 930 932 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 933 935 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1274 1276 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1634 1635 1596 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1827 1829 1785 1787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 306 311 <span type="species:ncbi:9940">sheep</span>
###xml 671 677 <span type="species:ncbi:9913">cattle</span>
###xml 885 890 <span type="species:ncbi:9940">sheep</span>
###xml 895 899 <span type="species:ncbi:9913">cows</span>
###xml 992 998 <span type="species:ncbi:9913">bovine</span>
###xml 1073 1078 <span type="species:ncbi:9606">human</span>
###xml 1310 1316 <span type="species:ncbi:9913">bovine</span>
###xml 1628 1632 <span type="species:ncbi:9913">cows</span>
###xml 1667 1673 <span type="species:ncbi:9913">bovine</span>
The proposed sequence of hormonal and molecular events leading to luteolysis involves positive feedback between the endometrium and ovary [2,14]. The role of estrogens and their receptors in initiation of luteolysis is not yet clear, but exogenous estrogen stimulates luteal regression [15,16]. Studies in sheep suggest that upregulated ER and oxytocin receptor expression in the luminal epithelium are essential for initiation of luteolysis [17,18]. During ovine pregnancy, conceptus secreted interferon tau (IFN-tau) is thought to block upregulation of ERalpha and oxytocin receptor expression in the luminal epithelium, which in turn suppresses luteolysis [18,19]. In cattle, the effects of IFN-tau on ERalpha in the luminal epithelium at maternal recognition of pregnancy are unknown. There are reported differences in the uterine location and timing of ERalpha expression between sheep and cows, and among research groups [4,17,20]. There are no reports of ERbeta localization in mature bovine endometrium, although our preliminary unpublished observations using anti-human ERbeta indicate that it is present in association with blood vessel walls but is not detectable in other endometrial cells. Using an antibody that localized ERalpha (clone ID5), Robinson et al. [20] detected ERalpha protein in the bovine uterine luminal epithelium at levels ranging from low to undetectable throughout the estrous cycle and pregnancy. Using a different ERalpha antibody (clone AER314) we detected strong staining for ERalpha in the uterine luminal epithelium only on day 16 of the estrous cycle and not in endometrium from pregnant cows [4]. The antibodies used in these bovine studies recognise different domains of the ERalpha, which have been shown previously to affect immunohistochemical reactivity in the luminal epithelium [21].
###end p 5
###begin p 6
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 373 378 <span type="species:ncbi:9606">women</span>
###xml 383 387 <span type="species:ncbi:9823">pigs</span>
###xml 428 434 <span type="species:ncbi:9913">bovine</span>
The anti-estrogen ICI 182, 780 is classified as a pure antiestrogen due to its lack of estrogen-like activity [22,23]. ICI 182,780 acts by binding ER, which causes disassociation of receptor associated proteins and results in impaired receptor dimerisation and increased receptor degradation [22,23]. In utero ICI 182, 780 blocks the trophic action of estrogen in rodents, women and pigs [23,24]. The effects of ICI 182, 780 in bovine endometrium have not yet been tested.
###end p 6
###begin p 7
###xml 149 150 139 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 154 156 141 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 360 361 337 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 365 367 339 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 491 492 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 496 498 459 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 159 165 <span type="species:ncbi:9913">bovine</span>
Our objectives were to investigate the effects of estrogen, the antiestrogen ICI 182, 780 and IFN-tau on the expression of ERalpha and integrin alphavbeta3 in bovine endometrium at the time of maternal recognition of pregnancy. We hypothesized that 1) IFN-tau alters expression of ERalpha in the luminal epithelium and prevents downregulation of integrin alphavbeta3 on day 16 of pregnancy and, 2) estrogen acting via ERalpha in the luminal epithelium causes downregulation of integrin alphavbeta3 in the subepithelial stroma on day 16 of the estrous cycle.
###end p 7
###begin title 8
Materials and Methods
###end title 8
###begin title 9
Animals
###end title 9
###begin p 10
###xml 509 510 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
This study was performed using 12 beef heifers of mixed breeds of similar age and weight (1.5-2 years; 520 +/- 31 kg) and exhibiting estrous cycles of 18-20 days. Heifers were checked for estrus twice daily throughout the experiment and trained for tie stalls one month prior to uterine infusions to adjust them to handling and confinement. Animals were synchronized to estrus using Estrumate (500 mug cloprostenol, Schering Canada Inc., QC, Canada), according to the synchronization schedule shown in Figure 1. All procedures performed were in accordance with the guidelines of the Canadian Council on Animal Care and were reviewed and approved by the Nova Scotia Agricultural College Animal Care and Use Committee.
###end p 10
###begin p 11
###xml 130 134 130 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
Synchronization schedule, heat detection and treatment regimes for heifers used in the study. Heifers were injected with Estrumate(R) 11 days apart and observed for heats after the second injection. All heifers were observed in standing heat within the same twelve hour period then observed for one cycle length of 18-20 days. Twelve days after non-induced estrus, heifers were injected a third time and observed for heats. At 6 pm, fourteen days following standing heat treatment began. Heifers received four uterine infusions 12 hr apart of either saline control, IFN-tau, estrogen or ICI 182,780. At 2 pm on day 16 of the estrous cycle, heifers were slaughtered and tissues were collected for analysis.
###end p 11
###begin title 12
Treatments
###end title 12
###begin p 13
###xml 350 352 345 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 754 756 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 876 878 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 951 953 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1134 1136 1120 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1270 1274 1256 1258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1454 1455 1438 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 713 717 <span type="species:ncbi:9913">cows</span>
###xml 843 848 <span type="species:ncbi:9940">sheep</span>
###xml 944 949 <span type="species:ncbi:9940">sheep</span>
###xml 1012 1016 <span type="species:ncbi:9913">cows</span>
###xml 1093 1099 <span type="species:ncbi:9913">bovine</span>
Following induced estrus, 3 heifers per treatment were randomly assigned to receive uterine infusion of a control solution (0.1% BSA in saline), or estradiol-17beta (117 ng/dose; Sigma, Saint Louis, MO), or ICI 182, 780 (3 mg/dose, Tocris, Avonmouth, Bristol, United Kingdom) or recombinant ovine IFN-tau (0.25 mg/dose = biological activity of 5 x 107 antiviral units/day; kindly provided by Drs. T. E. Spencer and F.W. Bazer, Texas A & M University, College Station, TX), from days 14 to 16 of the estrous cycle. The dose of estradiol was based on physiological levels, where the maximal venous-arterial difference in estradiol-17beta was multiplied by the average daily uterine arterial blood flow measured for cows on days 13-17 of the estrous cycle [25]. The dose used for ICI 182, 780 was based on an effective mg/kg dose administered to sheep via intrauterine infusion [26]. The dose for IFN-tau was selected based on previous studies in sheep [18] and increased to account for the greater uterine size of cows. Recombinant ovine IFN-tau has been shown to be as effective as recombinant bovine IFN-tau in preventing luteolysis [27]. Treatments were delivered every 12 h beginning at 6 pm on cycle day 14 via intrauterine infusion of both horns using 12 gauge Foley(R) catheters (Agtech, Manhattan, KS), which were positioned immediately anterior to the cervix prior to delivery of the 5 ml treatment volume. Treatment schedules are shown in Figure 1. At the time of treatment, the horns were gently massaged to ensure even distribution throughout the uterus. Volume and delivery mechanism were optimized prior to the experiment using reproductive tracts obtained from the local abattoir and in vivo using cull heifers.
###end p 13
###begin title 14
Tissue Collection
###end title 14
###begin p 15
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 341 343 341 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 747 748 737 738 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 752 754 739 741 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 872 873 859 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 874 876 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Uteri were collected within 30 min postmortem and morphological observations were made on the ovaries and reproductive tract. Data on ovarian morphology according to the methods of Ireland [28] were recorded to confirm cycle stage. For each heifer uterine, cervical and corpus luteum weight and length were recorded. Transverse sections 1 cm3 were dissected from the uterine horn ipsilateral to the corpus luteum and snap frozen in liquid nitrogen and stored at -80degreesC prior to preparation of cryostat cross-sections for immunohistochemical analysis. Intercaruncular endometrium was dissected from the ipsilateral horn, and snap frozen in liquid nitrogen for use in mRNA analysis. Caruncular tissue was not used for analysis of integrin alphavbeta3 since our previous work showed low expression in the caruncles regardless of the day of the cycle or pregnancy state [3,10].
###end p 15
###begin title 16
Immunohistochemistry
###end title 16
###begin p 17
###xml 14 15 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 19 21 12 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 81 82 70 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 83 84 72 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 452 453 436 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 457 459 438 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1201 1202 1170 1171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1206 1208 1172 1174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 721 726 <span type="species:ncbi:10090">mouse</span>
###xml 809 814 <span type="species:ncbi:9796">horse</span>
###xml 820 825 <span type="species:ncbi:10090">mouse</span>
Integrin alphavbeta3 and ERalpha protein were localized as previously described [3,4]. Briefly, 5-10 mum cryostat cross sections of endometrium were placed on Superfrost Plus slides (Fisher Scientific, Whitby, ON, Canada), air dried for 30 minutes, then fixed in acetone for 10 min and allowed to air-dry overnight before long-term storage at -80 C. Sections were rehydrated in PBS, blocked in 2% BSA in PBS and incubated with the monoclonal anti-alphavbeta3 from Novus Biologicals (clone BV4, Littleton, CO), a monclonal antibody to the amino terminus of the ERalpha (ER Ab-1, clone AER314 Neomarkers Inc., Union city, CA, USA) or to the carboxy terminus of the ERalpha (ER Ab-8, clone AER314), or the control, purified mouse IgG (Chemicon) for 2 h. Sections were then washed and incubated with biotinylated horse-anti-mouse secondary (Vector Laboratories, Burlingame, CA) for 30 min. Immunoreactivity was visualized using a fluorochrome conjugated streptavidin probe (Alexa-488, Molecular Probes, Inc., Eugene, OR, USA). Immunohistochemistry experiments were repeated on different days using tissue sections from all animals on each day. To determine effects of treatment on levels of integrin alphavbeta3 protein in uterine tissue, signal intensity of the intercaruncular subepithelial stroma was scored by two observers on a six-point scale (0-negative, 1-very weak, 2-weak but clearly positive, 3-intermediate, 4-high, and 5-very high). Four slides from each heifer were scored.
###end p 17
###begin title 18
Northern Blotting
###end title 18
###begin p 19
###xml 721 730 711 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1238 1240 1210 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1279 1288 1251 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1444 1446 1407 1409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 1845 1846 1804 1805 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1850 1852 1806 1808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
Total RNA was extracted from intercaruncular endometrium using Trizoltrade mark reagent (Life Technologies, Burlington, ON, Canada). Thirty five mug of total RNA was electrophoresed in denaturing 1.2% agarose, 2.2 M formaldehyde gels in 1X morpholinepropanesulfonic acid (MOPS, 0.02 M, pH 7.0, 2 mM sodium acetate, 1 mM EDTA pH 8.0) with appropriate markers for 2 h at 8 V/cm. Gels were blotted onto a positively charged nylon membrane (Roche Molecular Biochemicals, Laval, QC, Canada) using downward capillary transfer in alkaline buffer for 1 h. Two probing methods were used for two separate northern blots each with samples from each of the 12 animals. For the first blot, biotin labeled riboprobes were prepared via in vitro transcription (Roche). Blots were prehybridized in Ultrahybtrade mark (Ambion Inc, Austin, TX, USA) at 65 C for 30 min prior to the addition of the riboprobe. The blot was probed overnight at 65 C, and then washed at 65 C, 3 times for 20 min in 2X SSC/0.1% SDS (1X SSC = 150 mM sodium chloride and 15 mM sodium citrate pH 7.0). Hybridized probe was detected using chemiluminescence's performed according to the North2Southtrade mark kit protocol (Pierce Chemical Company, Rockford, IL). For the second blot, 32P-labeled riboprobes were prepared via in vitro transcription and membrane was prehybridized at 68 C for 30 min, followed by overnight hybridization in Ultrahybtrade mark at 68 C in the presence of 1 x 106 cpm probe/ml. After hybridization the membrane was washed at room temperature in 2X SSC/0.1% SDS (1X SSC = 150 mM sodium chloride and 15 mM sodium citrate pH 7.0) two times for 5 min each, followed by 2 washes at 68 C in 0.25X SSC/0.1% SDS for 15 min each. After washing the membrane was exposed to x-ray film using an intensifying screen at -80 C for three days. Intensity of integrin subunit alphavbeta3 mRNA and 18S rRNA bands were measured using the Gene Genius Bioimaging System (Fisher Scientific). As indicated above, Northern blots were repeated once so there were six observations per treatment (3 animals x 2 blots).
###end p 19
###begin title 20
Data Expression and Statistical Analysis
###end title 20
###begin p 21
###xml 292 293 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 297 299 281 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 360 361 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 365 367 342 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 758 760 731 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Data were checked for normality using the univariate procedure in SAStrade mark (Statistical Analysis Software Version 8, SAS Institute Inc., Cary, NC) and analyzed using the general linear models procedure to examine the effect of treatment on reproductive tract measurements, integrin alphavbeta3 protein immunohistochemical score, and integrin subunit alphavbeta3 mRNA. Day of experiment and day by treatment interactions were included in the immunohistochemistry and Northern blot analyses, although interactions were not significant. For northern blots, intensity of the 18S band within blot was included as a covariate to account for loading differences. Least squares means were compared using the Tukey-Kramer test. The selected alpha error rate was P </= 0.05.
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
Effects of Treatment on Uterine Characteristics
###end title 23
###begin p 24
###xml 216 218 216 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 334 336 334 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
From visual examination all uteri were similar among treatments in terms of size, tone or color. Although not statistically significant there was a tendency for heavier uterine weights from estrogen-treated heifers (P = 0.10). No differences were observed between uterine, cervical or corpus luteum measurements of weight and length (P > 0.05). Gross uterine observations are summarized in Table 1.
###end p 24
###begin p 25
Reproductive tract characteristics of heifers treated with interferon-tau (IFN-tau), estrogen or ICI 182, 780.
###end p 25
###begin p 26
Mean +/- standard error
###end p 26
###begin title 27
Effect of Treatment on Uterine Distribution of the Estrogen Receptor-alpha
###end title 27
###begin p 28
###xml 225 227 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 246 248 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 323 328 319 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A,2B</xref>
###xml 538 543 532 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C,2D</xref>
###xml 870 872 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 1063 1065 1057 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 1222 1227 1216 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E,2F</xref>
###xml 1293 1295 1287 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
Reactivity to ERalpha antibodies (AER314 and AER 311) was used to measure the effects of treatments. Immunofluorescent reactivity in the luminal epithelium was present in sections from control heifers using both AER314 (Fig. 2A) and AER311 (Fig. 2B), and a small proportion of stromal cells showed nuclear reactivity (Fig. 2A,2B, arrows). In some animals, there was reactivity in the glands (data not shown). In sections from heifers infused with IFN-tau, reactivities to AER314 and AER311 were low in comparison to control animals (Fig. 2C,2D). There was no reactivity in the luminal epithelium. In some animals, there was nuclear staining in the glandular epithelium of some sections (data not shown). In sections from ICI 182, 780 treated animals, there was little or no specific immunofluorescence was detected throughout the endometrium using antibody AER314 (Fig. 2G). In contrast, strong immunofluorescent signals were present in the nuclei of glands, stroma and luminal epithelium in sections from ICI 182, 780 treated animals using antibody AER311 (Fig. 2H). Estrogen treated heifers showed strong reactivity to both antibodies AER314 and AER311 in the nuclei of stroma, glandular epithelium and myometrium (Fig. 2E,2F), but only in the luminal epithelium using antibody AER311 (Fig. 2F).
###end p 28
###begin p 29
###xml 232 235 232 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-B</bold>
###xml 254 257 254 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C-D</bold>
###xml 274 277 274 277 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E-F</bold>
###xml 292 295 292 295 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G-H</bold>
###xml 328 333 <span type="species:ncbi:10090">mouse</span>
Immunofluorescent localization of the estrogen receptor using antibodies AER314 and AER311 in cyrostat cross-sections of endometrium obtained on day 16 of the estrous cycle after uterine infusion with a BSA-saline control solution (A-B), interferon-tau (C-D), ICI 182, 780 (E-F) or estrogen (G-H). A tissue section treated with mouse IgG in place of primary antibody is shown inset in A. Specific nuclear reactivity was present in some cells of the stroma (arrows) in control animals. LE - luminal epithelium, S - stroma, GE - glandular epithelium. Magnification for A-C was 400X, D,F,H was 200X and E,G 100X.
###end p 29
###begin title 30
###xml 61 62 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 66 67 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Effect of Treatment on Uterine Distribution of Integrin alphavbeta3
###end title 30
###begin p 31
###xml 34 35 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 39 41 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 85 87 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 254 255 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 472 474 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 668 670 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
For all treatments, integrin alphavbeta3 expression was detected in the stroma (Fig. 3A), myometrium and arteriolar smooth muscle (data not shown). In tissue sections from all animals, reactivity was low in the caruncles (eg., ICI 182, 780 panel of Fig. 3). Intense reactivity was observed in sections from estrogen and ICI 182, 780 treated heifers on stromal cells in close proximity to the basement membrane of the luminal epithelium of intercaruncular endometrium (Fig 3A, arrows). Accordingly, sections from ICI 182,780 and estrogen treated heifers had higher scores for subepithelial stromal cell staining than control or IFN-tau treated animals (P < 0.05) (Fig. 3B).
###end p 31
###begin p 32
###xml 44 45 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 49 51 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 95 96 88 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 572 573 563 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 651 652 636 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 656 658 638 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1123 1125 1105 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Immunofluorescent analysis of integrin alphavbeta3 in cryostat cross-sections of endometrium. (A) Immunoreactivity in sections from heifers treated with control solution, interferon-tau (IFN-tau), estrogen or ICI 182, 780. Diffuse staining was present in the dense stroma, low reactivity was observed in the glands (GE) and luminal epithelium (LE). Note the strong reactivity of intercaruncular subepithelial stromal cells (arrows) in sections from estrogen and ICI 182, 780 treated animals. CARS - caruncular stroma; ICS - intercaruncular stroma. Magnification was 100X. B) Least squares means +/- standard error of signal intensity of integrin alphavbeta3 in the subepithelial stroma (SES) by treatment (3 animals x 4 replicate experiments per treatment). Intensity was scored on a six point scale (0-negative, 1-very weak, 2-weak but clearly positive, 3-intermediate, 4-high, and 5-very high) and the data were subjected to ANOVA and the Tukey-Kramer multiple comparison of means to determine effects of treatment in comparison to the control. Asterisks indicate means that are significantly different from the control (P < 0.05).
###end p 32
###begin title 33
###xml 58 60 55 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
Effect of Treatment on Expression of Integrin Subunit beta3 mRNA
###end title 33
###begin p 34
###xml 91 93 88 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 153 155 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 223 225 217 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 390 391 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 63 69 <span type="species:ncbi:9913">bovine</span>
Northern blot analysis revealed a single 2.4 kb transcript for bovine integrin subunit beta3 corresponding to the published coding sequence of 2.364 kb [29]. In intercaruncular tissue samples levels of integrin subunit beta3 transcript were lowest from heifers infused with control solution and IFN-tau in comparison to tissue from estrogen and ICI 182,780 treated heifers (P < 0.05) (Fig. 4).
###end p 34
###begin p 35
###xml 57 59 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 129 130 126 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 430 432 422 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 518 519 510 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 585 587 572 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 792 794 777 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Effect of treatment onexpression of integrin subunit beta3 as detected by Northern blot analysis of intercaruncular endometrium. A) Three animals were used in each treatment group and received uterine infusions of either the saline control, interferon tau (IFN-tau), estrogen or ICI 182, 780. Thirty-five micrograms of total RNA from each animal were loaded per lane and biotin labeled riboprobes specific to integrin subunit beta3 were used for hybridization to the membrane. A single 2.4 kb transcript was detected. B) Least squares means +/- standard error for integrin subunit beta3 mRNA band intensity by treatment (3 animals/treatment x 2 replicate blots) were calculated using 18S as a covariate. Asterisks indicate means that are significantly different from the Control and IFN-tau (P < 0.05).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 739 740 731 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 741 743 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 744 746 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1292 1294 1280 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1432 1434 1420 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1435 1437 1423 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1628 1630 1608 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1862 1864 1842 1844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 70 76 <span type="species:ncbi:9913">bovine</span>
###xml 945 951 <span type="species:ncbi:9913">bovine</span>
###xml 1220 1226 <span type="species:ncbi:9913">bovine</span>
This is the first study to test the anti-estrogen ICI 182, 780 in the bovine uterus. No differences in uterine morphology were observed between treatments, which is not unexpected given the short exposure period, although estrogen but not ICI 182, 780 treated heifers tended to have heavier uterine weights. Unexpectedly, expression of ERalpha was readily detected in the luminal epithelium, stroma and glandular epithelium of sections from ICI 182, 780 treated heifers using antibody AER311. The distribution was similar to that observed in the estrogen-treated heifers with this antibody. Previous studies have shown that high levels of estrogen, such as those observed at estrus, are associated with this pattern of ERalpha expression [4,20,30]. Since ERalpha distribution did not differ between estrogen and ICI 182, 780 treated heifers and did differ from controls, ICI 182, 780 showed agonist, rather than antagonist, activity towards the bovine estrogen receptor. Interestingly, the reactivity to antibody AER314 was reduced in ICI 182, 780 but not estrogen treated animals, indicating that the effects of the two compounds are distinct. This may explain the lack of ICI 182, 780 effect on uterine morphology. In bovine endometrial explants, ICI 182, 780 was antagonistic to estrogen [31]. The reported mode of action of ICI 182, 780 is to disrupt translocation of receptors to the nucleus and increase receptor degradation [22,23], so a decline in ERalpha reactivity was expected regardless of antibody used. In the ewe, endometrial expression of ERalpha was lower in ICI 182, 780 treated than estrogen treated animals [26]. However similar to results presented here, in that species the ICI 182, 780 also showed partial agonist effects as evidenced by increased uterine weights, and GAPDH mRNA expression that did not differ from estrogen treated ewes [26].
###end p 37
###begin p 38
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 501 503 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 504 506 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 624 626 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 714 715 698 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 740 741 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 742 744 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1056 1058 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1059 1061 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1144 1146 1120 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1147 1149 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1463 1465 1431 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 41 47 <span type="species:ncbi:9913">bovine</span>
###xml 616 622 <span type="species:ncbi:9913">calves</span>
###xml 732 738 <span type="species:ncbi:9913">cattle</span>
###xml 1344 1348 <span type="species:ncbi:9913">calf</span>
Schuler et al. [21] localized ERalpha in bovine placentomes using four antibodies to ERalpha. Two of the antibodies recognized the carboxy terminus and positively reacted with maternal luminal epithelium, while the two amino terminal targeting antibodies did not. The current study is consistent with this pattern. The amino terminus of the ERalpha contains the AF-1 domain that undergoes a conformational change when the receptor is bound by estrogen and its activity is regulated by growth factors [22,32]. It is interesting that this antibody recognizes ERalpha in the luminal epithelium only in endometrium from calves [21], day 16 of the estrous cycle but not in tissues from other days of the estrous cycle [4], from pregnant cattle [4,21], or in endometrium from ICI 182,780 treated animals. The changes in AER314 binding may reflect changes in epitope accessibility related to a different functional conformation of the ERalpha. Possible causes include changes in receptor phosphorylation, estrogen binding, and/or in ERalpha cofactor association [22,32]. Impaired cofactor association is a reported mechanism of action of ICI 182,780 [22,23], thus it is conceivable that there was some antagonistic activity of the compound in the current study, which resulted in reduced recognition of the ERalpha by antibody AER314. Early postnatal calf uterine epithelium would be in a continued state of differentiation that is likely to require functional ERalpha [34], consistent with AER314 recognition of a functional form of the receptor. To summarize, the results indicate that the AER314 antibody recognizes a temporary change in the ERalpha, and may be used to detect altered ERalpha conformation as an early marker of the onset of luteolysis.
###end p 38
###begin p 39
###xml 187 189 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 190 192 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 193 195 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 427 429 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 430 432 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 465 466 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 3 8 <span type="species:ncbi:9940">sheep</span>
###xml 377 383 <span type="species:ncbi:9913">bovine</span>
###xml 652 655 <span type="species:ncbi:9913">cow</span>
In sheep, IFN-tau blocks ERalpha transcription in the luminal epithelium by stimulating binding of IFN regulatory factor 1 to interferon stimulated response elements on the ERalpha gene [19,35,36]. This action of IFN-tau is thought to prevent ERalpha expression and the onset of luteolysis. Estrogen receptor mRNA and protein are present in the luminal epithelium on day 16 of bovine pregnancy, although levels may be reduced [20,37]. As was observed in pregnancy [4], in the current study ERalpha were not detected by the AER314 or AER311 antibody in the luminal epithelium of heifers infused with IFN-tau. Together, these results suggest that in the cow, like the ewe, IFN-tau may affect ERalpha transcription.
###end p 39
###begin p 40
###xml 14 15 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 19 21 12 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 305 306 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 310 311 296 297 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 383 384 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 388 390 367 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 497 498 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 502 504 474 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 750 752 715 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 857 859 819 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1288 1290 1241 1243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1412 1414 1362 1364 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1464 1466 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1467 1469 1417 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1470 1472 1420 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1593 1595 1543 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1596 1598 1546 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1806 1808 1753 1755 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1814 1816 1761 1763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1817 1819 1764 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1836 1837 1779 1780 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1841 1843 1781 1783 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 2129 2131 2069 2071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1260 1266 <span type="species:ncbi:9913">bovine</span>
###xml 1374 1380 <span type="species:ncbi:10090">murine</span>
###xml 1385 1390 <span type="species:ncbi:9606">human</span>
###xml 1693 1698 <span type="species:ncbi:9606">human</span>
Integrin alphavbeta3 mRNA and protein expression were high in heifers receiving intrauterine infusions of estradiol. These results confirm what we have observed in cycling animals at estrus and suggest that at high levels following progesterone exposure, estrogen is a positive regulator of integrin alphavbeta3. Heifers infused with ICI 182, 870 also highly expressed integrin alphavbeta3 on day 16. As an antagonist, ICI 182, 780 would prevent the characteristic downregulation of integrin alphavbeta3 on cycle day 16 if endogenous follicular estrogen was the mediator of the event. As an agonist, it would upregulate endometrial ERalpha producing an estrus-like uterine environment, which also would be associated with high levels of integrin beta3 gene expression. Whether ICI 182, 780 acted as an antagonist or agonist with respect to the integrin beta3 gene thus cannot be distinguished. It is clear that AER314-reactive ERalpha expression in the luminal epithelium is not necessary for the cycle day 16 downregulation of the integrin, since both IFN-tau and ICI-182, 780 treated animals lacked this reactivity but only the former showed the integrin downregulation. The role of estrogen in this process remains to be determined. The promoter region for bovine integrin subunit beta3 has not been sequenced. While there are no estrogen response elements in the avian, murine and human integrin subunit beta3 promoters, both have AP-1 and SP-1 binding sites [11,38,39]. Many examples exist of ER interacting with the AP-1 and SP-1 transcription factors to confer estrogen responsiveness [40-42]. Alternatively, the transcription factor HOXA10 has been shown to be upregulated in cultured human endometrial cells in response to estrogen and progesterone and to regulate expression integrin subunit beta3 mRNA [43,44]. Integrin alphavbeta3 regulation in the subepithelial stroma is likely to involve an epithelial-stromal dialogue given that the cells of interest are in contact with the basal lamina. In other species it has been shown that the steroid responsiveness of epithelium and stroma is co-dependent in endometrium [45].
###end p 40
###begin p 41
###xml 78 79 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 83 85 74 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 249 250 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 254 256 234 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 434 435 406 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 439 441 408 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 442 444 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 636 637 601 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 641 643 603 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 743 745 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1016 1018 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1163 1164 1113 1114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1168 1170 1115 1117 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
Uterine infusion with IFN-tau did not prevent downregulation of integrin alphavbeta3 in intercaruncular subepithelial stroma on day 16 of the estrous cycle but did influence ERalpha in the luminal epithelium. Clearly downregulation of integrin alphavbeta3 in the subepithelial stroma of cyclic animals is not a necessary consequence of ERalpha changes in the luminal epithelium. Pregnancy does prevent downregulation of integrin alphavbeta3 [10]. It is possible that the exposure period in this experiment was too brief to elicit expression of epithelial or stromal interferon stimulated genes required for maintenance of integrin alphavbeta3 in the subepithelial stroma. Endogenous IFN-tau begins to be produced by trophoblast around day 12 [46], so pregnant animals would have two additional days to respond to the compound. After four days exposure to IFN-tau, the IFN-tau signaling molecules, signal transduction and activation of transcription 1 and 2, were observed in the subepithelial stroma of cyclic ewes [47]. On the other hand, other trophoblast factors or endometrial dialogue not induced by treatment with IFN-tau may be necessary for integrin alphavbeta3 regulation.
###end p 41
###begin p 42
###xml 183 184 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 188 190 177 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 348 349 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 353 355 329 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 416 417 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 421 423 388 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 545 546 508 509 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 550 552 510 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
To summarize, on day 16 of the estrous cycle both estrogen and ICI 182, 780 induced expression of ERalpha in the endometrium and blocked the transient downregulation of integrin alphavbeta3 on cycle day 16. Intrauterine infusion of IFN-tau suppressed changes in ERalpha protein reactivity in the luminal epithelium but did not affect integrin alphavbeta3 expression, suggesting IFN-tau may not prevent integrin alphavbeta3 downregulation during early pregnancy. We conclude that on day 16 of the estrous cycle, estrogen effects on integrin alphavbeta3 are indirect and do not directly involve ERalpha in the luminal epithelium.
###end p 42
###begin title 43
Acknowledgements
###end title 43
###begin p 44
The authors are grateful to Drs. Ted Semple, Joe Arosh and the staff at NSAC, Westmorland Institute and HUB meat packers for assistance with the animals. We thank Dr. Nancy H. Ing for her advice regarding ICI 182, 780 dose and Dr. Michel A. Fortier for critical reading of the manuscript. The Natural Sciences and Engineering Research Council of Canada supported this research through a postgraduate scholarship to S. K. and an individual research grant to L. A. M.
###end p 44
###begin article-title 45
###xml 53 59 <span type="species:ncbi:9913">cattle</span>
Collection, description and transfer of embryos from cattle 10-16 days after oestrus
###end article-title 45
###begin article-title 46
Luteolysis: a neuroendocrine-mediated event
###end article-title 46
###begin article-title 47
###xml 44 50 <span type="species:ncbi:9913">bovine</span>
Cyclic modulation of integrin expression in bovine endometrium
###end article-title 47
###begin article-title 48
###xml 100 106 <span type="species:ncbi:9913">bovine</span>
Oestrous cycle and pregnancy effects on the distribution of oestrogen and progesterone receptors in bovine endometrium
###end article-title 48
###begin article-title 49
Integrins: Bidirectional, allosteric signalling machines
###end article-title 49
###begin article-title 50
Luminal and glandular endometrial epithelium express integrins differentially throughout the menstrual cycle: implications for implantation, contraception and infertility
###end article-title 50
###begin article-title 51
Spatial and temporal analyses of integrin and Muc-1 expression in porcine uterine epithelium and trophectoderm in vitro
###end article-title 51
###begin article-title 52
###xml 71 77 <span type="species:ncbi:9557">baboon</span>
Distribution of integrins and the extracellular matrix proteins in the baboon endometrium during the menstrual cycle and early pregnancy
###end article-title 52
###begin article-title 53
###xml 79 84 <span type="species:ncbi:9940">sheep</span>
Muc-1, integrin, and osteopontin expression during the implantation cascade in sheep
###end article-title 53
###begin article-title 54
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 46 48 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 82 88 <span type="species:ncbi:9913">bovine</span>
Differential Expression of the integrin avbeta3 in caruncular and intercaruncular bovine endometrium
###end article-title 54
###begin article-title 55
Estrogen enhances alpha v beta 3 integrin expression by avian osteoclast precursors via stabilization of beta 3 integrin mRNA
###end article-title 55
###begin article-title 56
Epidermal growth factor and sex steroids dynamically regulate a marker of endometrial receptivity in Ishikawa cells
###end article-title 56
###begin article-title 57
###xml 84 85 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 129 135 <span type="species:ncbi:9913">bovine</span>
The effects of estrogen and progesterone on prostaglandins and integrin beta 3 (beta3) subunit expression in primary cultures of bovine endometrial cells
###end article-title 57
###begin article-title 58
The role of sex steroids in the oxytocin hormone system
###end article-title 58
###begin article-title 59
###xml 124 130 <span type="species:ncbi:9913">cattle</span>
Effect of estradiol-17 beta on peripheral plasma concentration of 15-keto-13,14-dihydro PGF2 alpha and luteolysis in cyclic cattle
###end article-title 59
###begin article-title 60
###xml 115 121 <span type="species:ncbi:9913">bovine</span>
Effects of the presence of a dominant follicle and exogenous oestradiol on the duration of the luteal phase of the bovine oestrous cycle
###end article-title 60
###begin article-title 61
Temporal and spatial alterations in uterine estrogen receptor and progesterone receptor gene expression during the estrous cycle and early pregnancy in the ewe
###end article-title 61
###begin article-title 62
Ovine interferon-tau inhibits estrogen receptor up-regulation and estrogen-induced luteolysis in cyclic ewes
###end article-title 62
###begin article-title 63
Ovine interferon tau suppresses transcription of the estrogen receptor and oxytocin receptor genes in ovine endometrium
###end article-title 63
###begin article-title 64
###xml 140 144 <span type="species:ncbi:9913">cows</span>
Expression of oxytocin, oestrogen and progesterone receptors in uterine biopsy samples throughout the oestrous cycle and early pregnancy in cows
###end article-title 64
###begin article-title 65
###xml 41 47 <span type="species:ncbi:9913">bovine</span>
Occurrence of estrogen receptor alpha in bovine placentomes throughout mid and late gestation and at parturition
###end article-title 65
###begin article-title 66
Basic guide to the mechanisms of antiestrogen action
###end article-title 66
###begin article-title 67
Similarities and distinctions in the mode of action of different classes of antioestrogens
###end article-title 67
###begin article-title 68
###xml 57 60 <span type="species:ncbi:9823">pig</span>
Endometrial development and adenogenesis in the neonatal pig: effects of estradiol valerate and the antiestrogen ICI 182,780
###end article-title 68
###begin article-title 69
###xml 78 82 <span type="species:ncbi:9913">cows</span>
Blood flow to the corpus luteum-bearing ovary and ipsilateral uterine horn of cows during the oestrous cycle and early pregnancy
###end article-title 69
###begin article-title 70
###xml 99 104 <span type="species:ncbi:9940">sheep</span>
ICI 182,780 acts as a partial agonist and antagonist of estradiol effects in specific cells of the sheep uterus
###end article-title 70
###begin article-title 71
###xml 100 104 <span type="species:ncbi:9913">cows</span>
Extension of corpus luteum lifespan and reduction of uterine secretion of prostaglandin F2 alpha of cows in response to recombinant interferon-tau
###end article-title 71
###begin article-title 72
###xml 75 81 <span type="species:ncbi:9913">cattle</span>
Follicular development during the four stages of the estrous cycle of beef cattle
###end article-title 72
###begin article-title 73
###xml 56 57 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 61 63 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 141 143 131 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 35 41 <span type="species:ncbi:9913">bovine</span>
###xml 81 109 <span type="species:ncbi:12110">foot and mouth disease virus</span>
###xml 130 136 <span type="species:ncbi:9913">bovine</span>
High efficiency utilization of the bovine integrin alphavbeta3 as a receptor for foot and mouth disease virus is dependent on the bovine beta3 subunit
###end article-title 73
###begin article-title 74
###xml 116 122 <span type="species:ncbi:9913">bovine</span>
Immunohistochemical assessment of estrogen receptor and progesterone receptor distribution in biopsy samples of the bovine endometrium collected throughout the estrous cycle
###end article-title 74
###begin article-title 75
###xml 64 70 <span type="species:ncbi:9913">bovine</span>
Oestradiol regulation of oxytocin receptor expression in cyclic bovine endometrium
###end article-title 75
###begin article-title 76
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
###end article-title 76
###begin article-title 77
###xml 52 55 <span type="species:ncbi:10116">rat</span>
Expression of estrogen receptor coactivators in the rat uterus
###end article-title 77
###begin article-title 78
Uterine differentiation as a foundation for subsequent fertility
###end article-title 78
###begin article-title 79
Expression of interferon regulatory factors one and two in the ovine endometrium: effects of pregnancy and ovine interferon tau
###end article-title 79
###begin article-title 80
Cloning of the ovine estrogen receptor-alpha promoter and functional regulation by ovine interferon-tau
###end article-title 80
###begin article-title 81
###xml 130 133 <span type="species:ncbi:9913">cow</span>
The effect of pregnancy on the expression of uterine oxytocin, oestrogen and progesterone receptors during early pregnancy in the cow
###end article-title 81
###begin article-title 82
###xml 36 42 <span type="species:ncbi:10090">murine</span>
Cloning and characterization of the murine beta(3) integrin gene promoter: identification of an interleukin-4 responsive element and regulation by STAT-6
###end article-title 82
###begin article-title 83
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human integrin beta3 gene is 63 kb and contains a 5'-UTR sequence regulating expression
###end article-title 83
###begin article-title 84
Transcriptional activation of insulin-like growth factor-binding protein-4 by 17beta-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes
###end article-title 84
###begin article-title 85
Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site
###end article-title 85
###begin article-title 86
Estrogen receptor interaction with estrogen response elements
###end article-title 86
###begin article-title 87
###xml 83 88 <span type="species:ncbi:9606">human</span>
HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium
###end article-title 87
###begin article-title 88
Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells
###end article-title 88
###begin article-title 89
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Paracrine regulation of epithelial progesterone receptor and lactoferrin by progesterone in the mouse uterus
###end article-title 89
###begin article-title 90
Recent developments and potentialities for reducing embryo mortality in ruminants: the role of IFN-tau and other cytokines in early pregnancy
###end article-title 90
###begin article-title 91
Interferon regulatory factor-two restricts expression of interferon-stimulated genes to the endometrial stroma and glandular epithelium of the ovine uterus
###end article-title 91

